Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

and the U.S. Military HIV Research Program heralded a preventative vaccine that gave protection in non-human primates, a result similar to what GeoVax published earlier last year. This report confirmed the prime-boost approach plus the use of similar genetic material in the vaccine to induce a protective immune response. In essence, they have validated our concepts and added some good news to the field. Results like this give the industry hope that an effective HIV vaccine is not far from reality and bolster our confidence that we are on the right track.

Financing and Corporate Development

We continue to benefit from tremendous financial, operational, and technical support provided to us by the NIH and the HVTN. The HVTN, funded by the NIH, is the largest worldwide clinical trials network dedicated to development and testing of promising HIV/AIDS vaccines. To date, the HVTN has conducted and funded all of our clinical trials for the preventative version of our vaccine. In addition to this support from the HVTN, we are the recipient of a $20 million Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institute of Allergy and Infectious Disease (NIAID). This five-year grant spans a period from September 2007 through August 2012, providing financial support for the development of the GM-CSF adjuvanted version of our preventative vaccine.

While we are deeply appreciative of the generous governmental support we receive, it does not cover the cost of all of our activities. Hence, fundraising will continue to be a primary and critical focus for 2012, as it was in 2011. Through our efforts during 2010 and 2011 we have developed numerous contacts and raised our exposure profile among potential institutional investors which we believe will benefit us going forward. In addition to our equity financing efforts, we will continue to seek out additional opportunities for non-dilutive financing through govern
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... TEL-AVIV , Israele, February 27, 2015 /PRNewswire/ ... continua nel suo sviluppo dell,innovativo sistema di monitoraggio ... il primo trial sull,uomo-   ... operante nello sviluppo di nuovo sistema per il ... congestizio (CHF), ha annunciato oggi di aver concluso ...
(Date:2/27/2015)... Feb. 27, 2015 An aggressive campaign to ... the rate of infection with a dangerous drug-resistant bacteria ... Clostridium difficile, or C.diff, is a bacterium that ... of the colon. A recent article in the New ... Infection in the United States " ...
(Date:2/27/2015)... PRUSSIA, Pa. , Feb. 27, 2015  In ... its ongoing commitment to the global bleeding disorders community, ... donating 2 million international units (IUs) of protein therapies ... an international not-for- profit organization which has worked to ... inherited bleeding disorders. The donation supports the WFH,s Global ...
Breaking Medicine Technology:Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3
... C. Lechleiter, Ph.D., chairman, president and chief executive officer ... ), today urged that biopharmaceuticals be included in transatlantic ... Council on Germany,s conference on "The Transatlantic Partnership in ... German State Secretary in the Federal Finance Ministry Jorg ...
... The U.S. Food and Drug Administration (FDA) has approved ... Vaccine, Adsorbed (Tdap)] for use in adults 65 years ... tetanus, diphtheria and pertussis (whooping cough). This approval makes ... this age group.  With this expanded indication, BOOSTRIX is ...
Cached Medicine Technology:Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 3GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 4
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics Outdoor ... student obtaining her Masters degree in social work at ... psychoeducation on substance use for teens at the local ... her studies. , “Even though these students are young, ... the high school and junior high school level,” said ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 On Thursday, February ... Make It Easy For Scammers To Steal Your Data , ... get their hands on a DIY phishing kit, or any ... also touched on another important point about how everyone’s cyber ... are often implemented, “like compromising legitimate content management systems or ...
(Date:2/28/2015)... February 28, 2015 The noted Toronto ... Facial Surgery was recently featured in the January/February 2015 ... magazine, Dr. David Ellis was featured in an article ... various cosmetic enhancements that Kim Cattrall has possibly undergone ... “Her forehead is smooth without horizontal lines or frown ...
(Date:2/28/2015)... 28, 2015 Javon Bea Mercy ... Harvard Hospital as stroke capable by the State of ... ambulance to Mercy Harvard Hospital. , The hospital was ... their ability to treat stroke according to national standards ... transporting stroke patients to bypass hospitals not designated as ...
Breaking Medicine News(10 mins):Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... NEW YORK, N.Y. (May 18, 2010) Autism Speaks, ... a major sponsor and scientific participant in the 2010 ... International Society of Autism Research, IMFAR brings together 1800 ... world who will share their latest research into autism,s ...
... disorder characterized by tics like grimacing, blinking and vocalizations, ... of several antipsychotic medications. But such drugs usually don,t ... have side effects, acting as sedatives, causing weight gain ... a multisite study led by a UCLA researcher has ...
... over 53, and those treated for depression typically most satisfied, ... those most likely to be satisfied with the results of ... being treated for depression, researchers say. , And, the ... to make a difference in whether they were pleased with ...
... But recent life losses may underlie the worrisome numbers, researchers ... in assisted-living and long-term care facilities may have a higher ... own homes, suggests a new report. , People over ... 100,000 people, but in a study of Italian people living ...
... , ... designed to be the ultimate advocate of people who want to be heard and make ... to write to the Congressional leaders on issues that concern them. , ... (PRWEB) May 18, 2010 -- GripeGenie.com, the ...
... Revatio, study finds , TUESDAY, May 18 (HealthDay News) ... progressive scarring of the lung tissue might get some ... new study finds. , The disease, called idiopathic pulmonary ... stiff, reducing the ability to breathe. There,s no known ...
Cached Medicine News:Health News:Autism Speaks to play key roles at the 2010 International Meeting for Autism Research 2Health News:Autism Speaks to play key roles at the 2010 International Meeting for Autism Research 3Health News:Behavior therapy effective in reducing tics in children with Tourette syndrome, study finds 2Health News:Behavior therapy effective in reducing tics in children with Tourette syndrome, study finds 3Health News:Older Patients More Apt to Be Happy With Plastic Surgery 2Health News:Suicide Risk May Be Higher in Senior Facilities 2Health News:Suicide Risk May Be Higher in Senior Facilities 3Health News:GripeGenie Unveils "Contact Congress" Service For Citizens Who Want to Make A Difference 2Health News:GripeGenie Unveils "Contact Congress" Service For Citizens Who Want to Make A Difference 3Health News:Viagra May Aid Those With Lung Fibrosis 2Health News:Viagra May Aid Those With Lung Fibrosis 3
... microtome with automatic fine/trim- feed system, ... precision cross roller bearings. For sectioning ... in biological, botany, and materials science. ... 90 mm can be accommodated. Performance, ...
... Extraordinarily high stability and precision as well ... section waste tray is an eclusive design ... 325 offers specimen retraction during return travel, ... microns and a section counter. With these ...
... The Leica SM2500 large scale heavy-duty sectioning ... and large sectioning techniques a real working ... mm and hard materials such as bone or ... be sectioned. The wide range of accessories, specially ...
... sliding microtome with automatic fine/trim- feed ... Maintenance-free precision cross roller bearings. For ... applications in biological, botany, and materials ... x 90 mm can be accommodated. ...
Medicine Products: